6-(methylsulfonyl)-3-pyridinyl 2,3,4-tri-O-acetyl-5-thio-β-D-xylopyranoside | 910647-90-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 6-(methylsulfonyl)-3-pyridinyl 2,3,4-tri-O-acetyl-5-thio-β-D-xylopyranoside
• 英文别名: [(3S,4S,5R,6R)-4,5-diacetyloxy-6-(6-methylsulfonylpyridin-3-yl)oxythian-3-yl] acetate
• CAS: 910647-90-4
• 化学式: C₁₇H₂₁NO₉S₂
• 分子量: 447.487
• InChiKey: UIZWOIOQIRCZHR-XLNGHYISSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  29
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  169
• 氢给体数：
  0
• 氢受体数：
  11

文献信息

• Novel Compounds Derived From 5-Thioxylose And Their Use In Therapeutics
  申请人：Barberousse Veronique

  公开号：US20080293768A1

  公开（公告）日：2008-11-27

  The invention relates to novel 5-thioxylose compounds, preferably derivatives of the 5-thioxylopyranose type, to the process for their preparation and to their use as active principles of drugs intended especially for the treatment or prevention of thrombosis or cardiac insufficiency.

  这项发明涉及新颖的5-硫木糖化合物，优选为5-硫木糖吡喃糖类衍生物，以及它们的制备过程和它们作为药物活性成分的用途，主要用于治疗或预防血栓形成或心脏功能不全。
• NOUVEAUX COMPOSES DERIVES DU 5-THIOXYLOSE ET LEUR UTILISATION THERAPEUTIQUE
  申请人：LABORATOIRES FOURNIER S.A.

  公开号：EP1861411A2

  公开（公告）日：2007-12-05
• US8148407B2
  申请人：——

  公开号：US8148407B2

  公开（公告）日：2012-04-03
• [EN] NOVEL COMPOUNDS DERIVED FROM 5-THIOXYLOSE AND THERAPEUTIC USE THEREOF<br/>[FR] NOUVEAUX COMPOSES DERIVES DU 5-THIOXYLOSE ET LEUR UTILISATION THERAPEUTIQUE
  申请人：FOURNIER LAB SA

  公开号：WO2006100413A2

  公开（公告）日：2006-09-28

  (EN) The invention relates to novel compounds derived from 5-thioxylose, preferably 5-thioxylopyranose-type derivatives, and to the preparation method thereof and the use of same as an active principle in medicaments which are intended, for example, for the treatment or prevention of thromboses or heart failure.(FR) L'invention concerne de nouveaux composés du 5-thioxylose, préférentiellement des dérivés de type 5-thioxylopyranose, ainsi que leur procédé de préparation et leur utilisation en tant que principe actif de médicaments, notamment destinés au traitement ou à la prévention des thromboses ou de l'insuffisance cardiaque.